Tandem Diabetes Care Inc (TNDM) - Product Pipeline Analysis, 2020 Update

Tandem Diabetes Care Inc (TNDM) - Product Pipeline Analysis, 2020 Update

Tandem Diabetes Care Inc (Tandem) is a medical device manufacturing company that designs and develops diabetic care products. The companys product portfolio includes t:slim X2 insulin pump, basal-IQ technology, software and applications, infusion sets and other pump accessories. It also provides product support services helping its clients to further customize their systems. The company distributes its products across various regions including Australia, Italy, New Zealand, and other Scandinavia regions (Sweden, Norway and Denmark). Tandem is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Tandem Diabetes Care Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company




Tandem Diabetes Care Inc Company Overview
Tandem Diabetes Care Inc Company Snapshot
Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview
Tandem Diabetes Care Inc – Pipeline Analysis Overview
Tandem Diabetes Care Inc - Key Facts
Tandem Diabetes Care Inc - Major Products and Services
Tandem Diabetes Care Inc Pipeline Products by Development Stage
Tandem Diabetes Care Inc Pipeline Products Overview
AutoSoft XC
AutoSoft XC Product Overview
Next Generation Gswim
Next Generation Gswim Product Overview
t:connect Mobile - Biometric Authentication
t:connect Mobile - Biometric Authentication Product Overview
t:connect Mobile - Decision Support
t:connect Mobile - Decision Support Product Overview
t:connect Mobile - Health App Integration
t:connect Mobile - Health App Integration Product Overview
t:connect Mobile - Mobile Bolus
t:connect Mobile - Mobile Bolus Product Overview
t:sport
t:sport Product Overview
Tandem Diabetes Care Inc - Key Competitors
Tandem Diabetes Care Inc - Key Employees
Tandem Diabetes Care Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Tandem Diabetes Care Inc, Recent Developments
Mar 02, 2020: Tandem Diabetes Care announces FDA designation of Basal-IQ technology as an interoperable automated glycemic controller
Feb 20, 2020: Data presented at International Diabetes Conference further demonstrate benefits of Tandem Diabetes care automated insulin delivery technologies
Feb 05, 2020: Tandem Diabetes Care recalls t:slim X2 insulin pump
Jan 15, 2020: Tandem Diabetes Care announces commercial launch of the t:slim X2 Insulin Pump with Control-IQ Technology in the United States
Jan 09, 2020: Tandem Diabetes Care appoints new executive vice president of strategy and corporate development
Jan 02, 2020: FDA approves UVA-developed artificial pancreas
Dec 23, 2019: Dexcom Partners with Tandem Diabetes Care on the t:slim X2 insulin pump in the UK, Sweden, Italy and Spain
Dec 13, 2019: Tandem Diabetes Care announces FDA clearance of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology
Dec 13, 2019: FDA authorizes first interoperable, automated insulin dosing controller designed to allow more choices for patients looking to customize their individual diabetes management device system
Nov 20, 2019: Tandem Diabetes Care announces Health Canada approval of t:slim X2 Insulin Pump with Basal-IQ predictive low-glucose suspend technology
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer


List Of Tables


Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview
Tandem Diabetes Care Inc Pipeline Products by Equipment Type
Tandem Diabetes Care Inc Pipeline Products by Indication
Tandem Diabetes Care Inc, Key Facts
Tandem Diabetes Care Inc, Major Products and Services
Tandem Diabetes Care Inc Number of Pipeline Products by Development Stage
Tandem Diabetes Care Inc Pipeline Products Summary by Development Stage
AutoSoft XC - Product Status
AutoSoft XC - Product Description
Next Generation Gswim - Product Status
Next Generation Gswim - Product Description
t:connect Mobile - Biometric Authentication - Product Status
t:connect Mobile - Biometric Authentication - Product Description
t:connect Mobile - Decision Support - Product Status
t:connect Mobile - Decision Support - Product Description
t:connect Mobile - Health App Integration - Product Status
t:connect Mobile - Health App Integration - Product Description
t:connect Mobile - Mobile Bolus - Product Status
t:connect Mobile - Mobile Bolus - Product Description
t:sport - Product Status
t:sport - Product Description
Tandem Diabetes Care Inc, Key Employees
Tandem Diabetes Care Inc, Subsidiaries
Glossary


List Of Figures


Tandem Diabetes Care Inc Pipeline Products by Equipment Type
Tandem Diabetes Care Inc Pipeline Products by Development Stage


Tandem Diabetes Care Inc (TNDM) - Product Pipeline Analysis, 2020 Update

Tandem Diabetes Care Inc (Tandem) is a medical device manufacturing company that designs and develops diabetic care products. The companys product portfolio includes t:slim X2 insulin pump, basal-IQ technology, software

USD 750 View Report

Tandem Diabetes Care Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Tandem Diabetes Care Inc Company Profile is a detailed strategic and analytical report on Tandem Diabetes Care Inc. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

India Diabetes Care Market, By Type of Product (Diabetes Drug and Diabetic Devices), By Diabetes Type (Type 1, Type 2 and Gestational Diabetes), By End-User (Hospital, Homeclinic, Homecare) By Region, Competition, Forecast & Opportunities, FY2026

India diabetes care market was valued at USD1530.3 million in value terms in FY2020 and is forecast to grow at CAGR of 7.94% in value terms to reach USD2408.39 million

USD 2950 View Report

Diabetes Care Devices Global Market Report 2021: COVID 19 Implications and Growth to 2030

Diabetes Care Devices Global Market Report 2021: COVID 19 Implications And Growth to 2030 from The Business Research Company covers this critical market and the impact on it from the

USD 5000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available